SSc Autoantibody Identified with Link to GI Dysfunction

If validated as a biomarker, anti-gephyrin autoantibodies could help identify patients at higher risk for GI symptoms like constipation.

Related Keywords

Maryland ,United States ,Texas ,Hospital For Special Surgery ,New York ,Subhash Kulkarni ,Zsuzsannah Mcmahan ,Kimberly Lakin ,Johns Hopkins University In Baltimore ,Weill Cornell Medical College ,Johns Hopkins Scleroderma Center ,Medscape Medical News ,Johns Hopkins University ,Special Surgery ,New York City ,Texas Health Science Center ,Scleroderma ,Crest Syndrome ,Constipation ,Systemic Sclerosis ,Diffuse Scleroderma ,Bloating ,Biomarker ,Iological Marker ,Gastrointestinal Disease ,Di Disease ,Nerve Cell ,Arthritis ,Oint Inflammation ,Hospitals ,Immunohistochemistry ,Mass Spectrometry ,Nerves ,Preventive Screening ,Screening ,Surgery ,Biologic Therapy ,